Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients

To report the efficacy, safety, and quality of life (QoL) on generic and innovator ibrutinib in Indian CLL patients. This was a single centre, prospective study of treatment-naive (TN), and relapsed/refractory (R/R) CLL patients receiving ibrutinib in India. The choice of innovator or generic ibruti...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Indian J Hematol Blood Transfus
Hoofdauteurs: Singh, Charanpreet, Jindal, Nishant, Youron, Padma, Malhotra, Pankaj, Prakash, Gaurav, Khadwal, Alka, Jain, Arihant, Sreedharanunni, Sreejesh, Sachdeva, Man Updesh Singh, Naseem, Shano, Varma, Neelam, Varma, Subhash, Lad, Deepesh P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer India 2020
Onderwerpen:
Short Communication
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012457/
https://ncbi.nlm.nih.gov/pubmed/33867740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-020-01378-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items